Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nOPV3 in Healthy Young Children, Infants, and Neonates
NCT05654467Phase 2Recruiting
- Sponsor
- PATH
- Start
- Dec 2023
- Primary completion
- Mar 2027
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of novel oral polio vaccine type 3 in poliomyelitis, sponsored by PATH. Started Dec 2023; status: recruiting.
02
Drugs
novel oral polio vaccine type 3
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT05654467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05654467.